Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...

An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...

China was producing tiles that were not easily available in the United States or from other parts of the world ... of Plastic Based Material Flooring (PBM Flooring) reads as follows, “Tile ...

CVS Health owns Caremark and Cordavis, and its PBM's formulary contains a Cordavis-branded biosimilar. "Confusing? Absolutely. Profitable for the PBMs? Certainly. Good for plan sponsors and patients?

“The central question here is whether the PBM industry should continue to be able to take income from both the manufacturer and the buyer.” The complexity of the business and the lack of ...